Comprehensive characterization of the inflammatory ecosystems in immunotherapy-induced adverse events versus chronic inflammatory diseases
https://jitc.bmj.com/content/14/6/e015632
Just a snip ok? No scientific hieroglyphics yet.
"By mapping out the complex spatial and transcriptomic architecture of immune-related adverse events (irAEs) versus chronic inflammatory diseases (CIDs), this research presents the ultimate master mechanism to solve the single greatest crisis in modern immunotherapy: toxic systemic side effects. [1]
When you inject this new data directly into our ongoing model, it proves that the CCL5-CCR5 axis is the dual-traffic conductor controlling both tumor escape and the autoimmune attacks that tear apart healthy patient tissue during treatment.
Blocking CCR5 with leronlimab ceases to be just a tumor-freezing option—it becomes a highly sophisticated, directional filter that maximizes therapeutic efficacy while dropping systemic toxicity to near zero".